1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants is sponsored by American Association for Cancer Research (AACR). These grants aim to stimulate creative approaches to translate basic research into new treatment options for kidney cancer. The funding supports expenses related to research projects, including salary, benefits, supplies, equipment, and publication charges.
While not exclusively focused on HLRCC, the program's emphasis on innovation in kidney cancer research makes it relevant. Past recipients have focused on altered metabolic pathways in cancer and inborn errors of metabolism, which aligns with HLRCC's metabolic underpinnings related to fumarate hydratase deficiency.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants | Grants | AACR Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Patient / Caregivers / Public Researchers / Professionals Information for Current Grantees Research Training and Fellowships Career Development Awards Independent Research Grants AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants Start of Grant Term July 1, 2026 Application Deadline March 12, 2026 1:00 PM Additional Information Additional details regarding this grant can be found in the Program Guidelines and Application Instructions.
Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted application. The 2026 AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants seek to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
These grants provide $50,000 over one year for expenses related to the research project, which may include salary and benefits of the grant recipient, collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses.
Indirect costs are not allowable expenses. Program Guidelines and Application Instructions are available for download. Please read all eligibility criteria and instructions carefully before submitting an application.
Research Project Criteria These grants will support basic, translational, and/or clinical research projects that examine important and druggable* novel targets and/or biomarkers that are relevant for kidney cancer.
Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to kidney cancer research. *For the purposes of this grant program, a "druggable" target is defined as a nucleic acid or a protein (e.g., an enzyme, a receptor) whose activity can be modified by a drug.
The drug can be a small- molecular weight chemical compound or a biological, such as an antibody or a recombinant protein. The target should have been shown to be effective/mechanistically involved in cancer by relevant in vitro or in vivo models.
A cancer-related biomarker might be a protein, a nucleic acid, or a metabolite that can be measured in biological fluids, tissue, or isolated cells for the diagnosis, monitoring, prognosis, or stratification of patients. At the start of the grant term on July 1, 2026, applicants must: Have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
Be an independent investigator working at an academic, medical, or non-profit research institution. If eligibility is based on a future position, the position must be confirmed at the time of application, and CANNOT be contingent upon receiving this grant.
If the future position is at a different institution than the applicant’s current institution, the applicant must contact AACR’s RGA at [email protected] before submitting their application for information on additional verification materials/signatures that may be required. There are no citizenship or geographic requirements.
However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied. AACR Membership Requirements Applicants must be AACR Active members in good standing (dues paid for the current year).
Please be informed that no dues are required for members located in countries building cancer research capacities ( view list of eligible countries here ). Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the application deadline. Nonmembers can apply for membership online.
Please review the Membership Categories for the category that best fits your qualifications. Nonmembers must obtain a statement of support from a nominator who is an Active AACR member in good standing (dues paid for the current year). Nonmembers requiring assistance with finding a nominator may email [email protected] and include your geographical location to receive a list of members in your area to contact for nominations.
For more information check the membership FAQ . Members can renew their membership through myAACR . You will need your logon (email address) and password to access the member portal.
If you require assistance logging in, please submit a help form . Lapsed members must be members in good standing by the application deadline and should contact the Membership Department at [email protected] for assistance. The AACR requires applicants to submit an online application by 1 p.
m. U.S. Eastern Time on Thursday, March 12, 2026, using the ProposalCentral website . Download Program Guidelines and Application Instructions online .
block needs to be placed in the location where the link block will be displayed--> The Progression of Cancer Research Funding, Prestigious Research Grants Professional Development Opportunities
According to the current listing, eligibility includes: Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. They must be an independent investigator working at an academic, medical, or non-profit research institution. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was March 12, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants is funded by American Association for Cancer Research (AACR). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article